Beximco Pharma

Last updated
Beximco Pharmaceuticals Ltd
Company type Limited
DSE:  BXPHARMA
LSE:  BXP
Industry Pharmaceutical
Founded1980
Headquarters Dhanmondi, Dhaka, Bangladesh
Key people
 Iqbal Ahmed (Managing Director)
RevenueIncrease2.svg৳3926.7 crore (US$370 million) (2023) [1]
Increase2.svg৳691.2 crore (US$64 million) (2023) [1]
Decrease2.svg৳461.4 crore (US$43 million) (2023) [1]
Number of employees
4,523 (2019) [2]
Website www.beximcopharma.com

Beximco Pharmaceuticals Ltd, also known as Beximco Pharma (stylised as BEXIMCO PHARMA) is a Bangladeshi multinational pharmaceutical company. [3] It is a part of Bangladesh Export Import Company Limited (BEXIMCO). [4]

Contents

History

Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. [5] Today Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. It was the first drug company from Bangladesh to sell its products in the US. [6]

In May 2020, the company introduced the world's first generic remdesivir for COVID-19 treatment. [7] [8] [9] Beximco Pharma became the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along with Eskayef Pharmaceuticals. [10] [11] Beximco Pharma's branded generic version of molnupiravir is being marketed as Emorivir. [12]

Factories

Beximco Pharma manufacturing facilities are spread across a 20-acre (81,000 m2) site located in Dhaka, Bangladesh. [13] The facilities consist of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.

Exports

On August, 2007, Beximco exported its medicines to the Philippines, the 5th country of the 10-member Association of South East Asian Nations (ASEAN) to import Beximco's drugs.

Related Research Articles

<span class="mw-page-title-main">Pharmaceutical industry</span> Industry involved with discovery, development, production and marketing of drugs

The pharmaceutical industry is an industry involved in medicine that discovers, develops, produces, and markets pharmaceutical goods for use as drugs that function by being administered to patients using such medications with the goal of curing and/or preventing disease. Pharmaceutical companies may deal in "generic" medications and medical devices without the involvement of intellectual property, in "brand" materials specifically tied to a given company's history, or in both within different contexts. The industry's various subdivisions are all subject to a variety of laws and regulations that govern entire financial processes including the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020, in total, and this showed a compound annual growth rate (CAGR) of 1.8% given the results of recent events.

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

<span class="mw-page-title-main">Gilead Sciences</span> American pharmaceutical company

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

Bangladesh Export Import Company Limited, commonly known by its trade name BEXIMCO, is a Bangladeshi multinational conglomerate holding company, headquartered in Dhaka, Bangladesh. It was founded in the early 1970s.

<span class="mw-page-title-main">Cefpodoxime</span> Antibiotic

Cefpodoxime is an oral, third-generation cephalosporin antibiotic available in various generic preparations. It is active against both Gram-positive and Gram-negative organisms with notable exceptions including Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. It is typically used to treat acute otitis media, pharyngitis, sinusitis, and gonorrhea. It also finds use as oral continuation therapy when intravenous cephalosporins are no longer necessary for continued treatment.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Hetero Drugs</span> An Indian pharmaceutical company

Hetero Drugs is an Indian pharmaceutical company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.

<span class="mw-page-title-main">Square Pharmaceuticals</span> Bangladeshi pharmaceutical company

Square Pharmaceuticals Ltd. is a Bangladeshi multinational pharmaceutical company. It was founded in 1958 by Samson H. Chowdhury along with three of his friends PK Saha, Kazi Harunur Roshid and Radhabinod Rai as a private firm. It went public in 1991 and is listed on the Dhaka Stock Exchange and on the Chittagong Stock Exchange Square Pharmaceutical started to export different antibiotics and medicine across the world from 1987. Now it exports its medicine to 36 countries of the world.

<span class="mw-page-title-main">Zydus Lifesciences</span> Indian multinational pharmaceutical company

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.

Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group. Simeen Rahman is the Managing Director and CEO of the company.

<span class="mw-page-title-main">Incepta Pharmaceuticals</span> Bangladeshi pharmaceutical company

Incepta Pharmaceuticals Limited is a Bangladeshi pharmaceutical company based in Dhaka that manufactures and markets generic drugs and vaccines. Abdul Muktadir is the chairman of the company.

The ACME Laboratories Ltd. is a pharmaceutical company based in Bangladesh. It is part of the ACME Group of Companies. Mizanur Rahman Sinha is the managing director and largest shareholder of the company and Nagina Afzal Sinha is the chairperson.

General Pharmaceuticals Limited is a pharmaceutical company based in Dhaka, Bangladesh since 1987.

<span class="mw-page-title-main">Salman F Rahman</span> Member of Jatiya Sangsad

Salman Fazlur Rahman is a Bangladeshi businessman, and a member of the Jatiya Sangsad. He is the Private Industry and Investment Adviser to Bangladesh Prime Minister Sheikh Hasina in the rank of a cabinet minister. Earlier, he served as the private sector development affairs adviser to her. He was ranked 1685th on the list of billionaires in the world published by Beijing-based Hurun Gobal in 2017. He is the vice chairman of BEXIMCO Group, one of the largest conglomerates in Bangladesh. He was the president of several trade bodies including Association of Television Channel Owners (ATCO).

Beacon Pharmaceuticals PLC is a Bangladeshi pharmaceutical company that develops generic version of medications.

<span class="mw-page-title-main">Natco Pharma</span> Indian pharmaceutical company

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US.

<span class="mw-page-title-main">Molnupiravir</span> Antiviral medication

Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID‑19 in those infected by SARS-CoV-2. It is taken by mouth.

Square Group is a Bangladeshi diversified multinantional conglomerate based in Dhaka. Samuel S Chowdhury is the chairman and Tapan Chowdhury is managing director of Square Group. Square Group has 60 thousand employees.

<span class="mw-page-title-main">Ensitrelvir</span> COVID-19 SARS-CoV-2 3CL-protease-inhibitor antiviral drug

Ensitrelvir, sold under the brand name Xocova is an antiviral medication used as a treatment for COVID-19. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor. It is taken by mouth.

References

  1. 1 2 3 "Beximco Pharmaceuticals Ltd". WSJ. Retrieved 18 January 2024.
  2. ↑ "Beximco Pharma Annual Report 2018-19" (PDF). Retrieved 23 December 2019.
  3. ↑ "BD firm plans to export version of Tamiflu". Daily Times . 2006-04-05. Archived from the original on 2011-06-06. Retrieved 2008-03-08.
  4. ↑ "Bangladesh forays into US market with Beximco Pharma". bdnews24.com. Retrieved 2016-10-03.
  5. ↑ Letter, The Pharma. "Beximco Pharma Q3 revenue up". www.thepharmaletter.com. Retrieved 2016-10-03.
  6. ↑ "US FDA approves Beximco Pharma's blood pressure drug". Dhaka Tribune. Archived from the original on 2016-09-30. Retrieved 2016-10-03.
  7. ↑ "Beximco introduces remdesivir for Covid-19 treatment". The Daily Star. 2020-05-21. Retrieved 2020-05-24.
  8. ↑ "Beximco Pharma introduces world's first generic Remdesivir for COVID-19 treatment". The Financial Express. Dhaka. Retrieved 2020-05-24.
  9. ↑ Siddiqui, Zeba (2020-05-05). "Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir - COO". Reuters. Retrieved 2021-03-06.
  10. ↑ Pilla, Viswanath (December 30, 2021). "Bangladesh drug maker Beximco launches world's first generic of Pfizer's COVID antiviral". The Economic Times. Retrieved June 26, 2024.
  11. ↑ Report, TBS (January 20, 2022). "Beximco Pharma gets license for oral anti-Covid drug". The Business Standard. Retrieved June 26, 2024.
  12. ↑ "Merck's COVID-19 pill molnupiravir hits Bangladesh markets". The Financial Express. June 26, 2024. Retrieved June 26, 2024.
  13. ↑ Report, Star Business (April 30, 2024). "Beximco Pharma's Q3 profits soar 51%". The Daily Star. Retrieved June 26, 2024.{{cite web}}: |first= has generic name (help)
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.